Climb Bio (CLYM) Long-Term Investments (2021 - 2026)
Climb Bio's Long-Term Investments came in at $56.1 million for Q2 2026, down 45.4% from $102.7 million a year earlier but up 52.7% from the prior quarter.
Powered by 
Analysis
Climb Bio (CLYM) Long-Term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Climb Bio's Long-Term Investments was $59.57 million, down 3.3% from FY2024.
- Long-Term Investments carries a four-year compound annual growth rate of 24.3% (FY2021 to FY2025).
- Going back by year, Long-Term Investments was $61.61 million in FY2024 and $24.92 million in FY2021.
- The five-year range for quarterly Long-Term Investments is $6.96 million (Q3 2022) to $102.7 million (Q2 2025).
- Year-over-year, Long-Term Investments has declined for three consecutive quarters, with growth averaging 37.5% over the last four quarters.
- Business Quant data shows CLYM's Long-Term Investments at $36.74 million (Q1 2026), $59.57 million (Q4 2025) and $88.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Climb Bio | 873.49 Mn | 873.49 Mn | - | 56.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.10 Mn |
| Mar 31, 2026 | 36.74 Mn |
| Dec 31, 2025 | 59.57 Mn |
| Sep 30, 2025 | 88.93 Mn |
| Jun 30, 2025 | 102.70 Mn |
| Mar 31, 2025 | 99.78 Mn |
| Dec 31, 2024 | 61.61 Mn |
| Sep 30, 2024 | 24.58 Mn |
| Sep 30, 2022 | 6.96 Mn |
| Jun 30, 2022 | 11.70 Mn |
| Mar 31, 2022 | 25.91 Mn |
| Dec 31, 2021 | 24.92 Mn |
| Sep 30, 2021 | 23.62 Mn |
API Access
Climb Bio Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=CLYM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "CLYM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=CLYM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();